1,682
Participants
Start Date
March 1, 2019
Primary Completion Date
June 30, 2019
Study Completion Date
July 1, 2019
Terlipressin
Continuous or intermittent intravenous infusion of terlipressin was given.
Somatostatin
Continuous or intermittent intravenous infusion of somatostatin was given.
Octreotide
Continuous or intermittent intravenous infusion of octreotide was given.
Center for Liver Cirrhosis, The Fifth Medical Center of PLA General Hospital, Beijing
Difficult & Complicated Liver Diseases and Artificial Liver Center, Beijing YouAn Hospital, Capital Medical University, Beijing
Department of Gastroenterology, The First Affiliated Hospital of China Medical University, Shenyang
Department of Critical Care Medicine, The Sixth People's Hospital of Shenyang, Shenyang
Department of Gastroenterology, Air Force Hospital of Northern Theater Command, Shenyang
Department of Gastroenterology, General Hospital of Northern Theater Command (formerly called General Hospital of Shenyang Military Area), Shenyang
Department of Gastroenterology, Shandong Provincial Hospital Affiliated to Shandong University, Jinan
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou
Department of Gastroenterology, The First Affiliated Hospital of Nanchang University, Nanchang
Liver Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou
Department of Hepatobiliary Disease, 900 Hospital of the Joint Logistics Team (formerly called Fuzhou General Hospital), Fuzhou
Department of Gastroenterology, General Hospital of Western Theater Command, Chengdu
Department of Gastroenterology, Xi'an Central Hospital, Xi'an
Eastern Hepatobiliary Hospital of the Second Military Medical University, Shanghai
General Hospital of Shenyang Military Region
OTHER